Nerium Youth Factor Antioxidant Boost Powder
Natural health product licensed in Canada
- Other names
- Nerium Youth Factor, Youth Factor, Youth Factor(TM) Antioxidant Boost Powder (Berry)
- Licence holder
- Neora, LLC
- NPN or DIN-HM
- 80085118
- Status
- Inactive licence
- Licence date
- 10 May 2018
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium corymbosum Source : Fruit | 0.261 mg | Not calculated |
| Daucus carota Source : Racine | 0.285 mg | Not calculated |
| Niacine Source : Niacine | 20.6 mg | Not calculated |
| Mélange de fruits Source : Fruit blend | 292.81 mg | Not calculated |
| Riboflavine Source : Riboflavine | 2.04 mg | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 1.73 mg | Not calculated |
| Biotine Source : Biotine | 309 mcg | Not calculated |
| Beta vulgaris Source : Racine | 500 mg | Not calculated |
| Vitis rotundifolia Source : Graine(s) | 5 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 35:1 Dry plant equivalent : 875 mg Potency : 45 % Epigallocatechin 3-gallate | 25 mg | Not calculated |
| Rubus occidentalis Source : Fruit | 0.129 mg | Not calculated |
| Rubus plicatus Source : Fruit | 0.156 mg | Not calculated |
| Prunus cerasus Source : Fruit | 0.129 mg | Not calculated |
| Vaccinium macrocarpon Source : Fruit | 0.519 mg | Not calculated |
| Rubus idaeus Source : Fruit | 0.519 mg | Not calculated |
| Fragaria x ananassa Source : Fruit | 0.39 mg | Not calculated |
| Citrus paradisi Source : Fruit | 10 mg | Not calculated |
| Vitis vinifera Source : Fruit skin | 10 mg | Not calculated |
| Vitis vinifera Source : Fruit | 10 mg | Not calculated |
| Euterpe oleracea Source : Fruit | 0.207 mg | Not calculated |
| Linum usitatissimum Source : Graine(s) | 3 mcg | Not calculated |
| Pectine Source : Malus domestica - Fruit | 3 mcg | Not calculated |
| Brassica oleracea var. viridis Source : Feuille | 25 mg | Not calculated |
| Agastache rugosa Source : Feuille | 22.75 mg | Not calculated |
| Ficus carica Source : Fruit | 2.75 mg | Not calculated |
| Lycium barbarum Source : Fruit | 4.5 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 1,342 Unités d'activité du xylanase | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 46.64 FCC BGU | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.1 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 7.8 mcg | Not calculated |
| Pterocarpus marsupium Source : Stem heartwood Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 3.5 mg Potency : 5 % Pterostilbene | 0.5 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 49.88 mg | Not calculated |
| Potassium Source : Potassium | 251 mg | Not calculated |
| Phosphore Source : Phosphate de potassium dibasique | 101 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 98 % Polyphenols | Not specified | Not calculated |
Non-medicinal ingredients
Saveur de framboise, Gomme de Guar, Dioxyde de silicium, Isomaltulose, Feuille de Stevia rebaudiana, Feuilles de Camellia Sinensis, Acide citrique, Baie d'Aristotelia chilensis, Amidon alimentaire, modifié, Maltodextrine, Saveur de fraises mélangées, Jus de citron concentré, Saveur de lime, Carbonate de magnésium, Poudre de jus d'orange, Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 packet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain the body's ability to metabolize nutrients. Digestive enzyme(s). Helps in energy metabolism, tissue formation and bone development. Helps in energy production. Helps in the normal function of the immune system. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain normal electrolyte balance. Helps to maintain proper muscle function, including the heart muscle. Provides antioxidants for the maintenance of good health. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breast feeding, are taking blood thinners or prescription medication, have diabetes, a history of kidney stones, liver disorder or develop symptoms of liver trouble, or an iron deficiency. May cause gastrointestinal discomfort; in which case, discontinue use and consult a health care practitioner. Do not use with other potassium-containing supplements, potassium-containing salt-substitutes, or if you have a gastrointestinal ulceration or obstruction. Hypersensitivity/allergy has been known to occur to acai or plants of the Arecaceae family. In such a case, discontinue use. Hypersensitivity/allergy has been known to occur; in such a case, discontinue use. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Source
Official Health Canada record, licence 80085118
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium corymbosum
Read the warning, when it applies and the studies cited
Blueberry
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Daucus carota
Read the warning, when it applies and the studies cited
CARROT - DAUCUS CAROTA SUBSP. SATIVUS
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 6,000 μg of beta-carotene, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Vaccinium macrocarpon
Read the warning, when it applies and the studies cited
CRANBERRY - VACCINIUM MACROCARPON
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
DRIED CRANBERRY JUICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Euterpe oleracea
Read the warning, when it applies and the studies cited
ACAI – EUTERPE OLERACEA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Linum usitatissimum
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.